03/17/2023
PCF Researcher Brian Michael Olson, PhD, cancer immunotherapy investigator, dies at 41
The Prostate Cancer Foundation (PCF) community has lost all too early a good friend, esteemed colleague, and brilliant young cancer investigator, Brian Michael Olson, PhD. Brian most recently was serving as an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, where he. Read More
03/16/2023
Creamy Polenta with Mushrooms and Spinach
Polenta is a traditional Italian dish made with ground corn. This simple, comforting dinner comes together in little more than 20 minutes—perfect on a busy weeknight. You can customize it to suit your needs and tastes: make it plant-based or gluten-free if desired. Nutritionally, compared to corn, you’d get a. Read More
03/10/2023
Walking Your Way to Better Health
First of all, congratulations and HUGE THANKS to all of the more than 3000 participants in this 3rd annual 100 Miles in March challenge. As we approach the halfway point of the month, some of you are actually more than halfway to 100 Miles! If you’re not moving quite that. Read More
03/09/2023
Highlights of the American Society of Clinical Oncology – Genitourinary Cancers Symposium 2023
Clinicians and researchers gathered last month at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) in San Francisco. Hundreds of presentations covered advances in screening, diagnosis, treatment, monitoring, and survivorship in prostate and other GU cancers. Below is a sampling of some of the important findings. You. Read More
03/06/2023
5 Reasons to Exercise TODAY!
Congratulations on joining PCF's 100 Miles in March challenge! While most folks will likely walk or run most of their miles, you're welcome to mix it up, any way you like. We know that some participants may need to mix it up due to injury, recovery, their doctor's advice....or just. Read More
03/03/2023
Hawks Raise $144,000 for Fifth Annual ‘Black History Month Assist Challenge’ to Support the Prostate Cancer Foundation
FOR IMMEDIATE RELEASE: 3/3/23 CONTACT: Max Strauss or Malynda Washington, Hawks Brand Communications, [email protected] More than $777,000 Donated to the Prostate Cancer Foundation Since the Launch of Campaign in 2019 ATLANTA – Earlier this evening at the Hawks’ game, the Atlanta Hawks Foundation presented a check of $144,000 to the. Read More
03/03/2023
Prostate Cancer Foundation-Funded Genetic Study of Men of African Ancestry Finds New Risk Factors for Prostate Cancer
The largest-ever genetic study of prostate cancer in Black men identified nine new gene variants that increase risk, determined polygenic risk score can predict more aggressive disease. LOS ANGELES, Calif., March 3, 2023 – One in six Black men in the United States will be diagnosed with prostate cancer in. Read More
03/02/2023
Prostate Cancer Foundation-Funded Research Identifies Promising Combination Immunotherapy Treatment for Advanced Prostate Cancer
Study defines a mechanism by which prostate cancer cells evade the immune system and a possible new precision immunotherapy regimen that counters it in an aggressive form of advanced disease. LOS ANGELES, Calif., March 2, 2023 – Immunotherapies have successfully treated many types of cancer with the exception of advanced. Read More
03/02/2023
Promising Personalized Targeted/Immunotherapy Combination Treatment Identified For an Aggressive Form of Advanced Prostate Cancer
The majority of prostate cancers are diagnosed at an early stage, such that patients can be closely monitored without treatment, or are cured with local treatment. However, recurrent and metastatic disease often progresses to an advanced stage and becomes resistant to therapy, known as metastatic castration-resistant prostate cancer (mCRPC): nearly. Read More
03/02/2023
Should You Run or Walk?
This month’s challenge is all about lacing up your sneakers and hitting the pavement, trail, or treadmill. It all counts: walking, hiking, trail-running, race-walking, even pool running. Is it better to run or walk? The decision is personal. Let’s consider a few factors that might help you choose. Which is. Read More